Biocon bounces back with ₹85 crore profit

Business Nov 12, 2025

Biocon just flipped its fortunes, posting an ₹85 crore net profit this quarter after a loss last year.
The big boost came from its biosimilars business, which jumped 25% and brought in ₹2,721 crore—making a real difference to the bottom line.

Revenue climbed 11% year-on-year to ₹4,389 crore

Revenue climbed 11% year-on-year to ₹4,389 crore, and operating profits (EBITDA) rose 29% with better margins.
Biocon also paid off major debts and opened a new manufacturing site in New Jersey.
Plus, they launched new generic drugs and expanded their research arm globally—showing they're not slowing down anytime soon.